← Back to Patent Explorer
US4716147A Expired / Lapsed US ⏱️ 0.0 years remaining

Synthetic airial peptides

Assignee: Monsanto Co
•
Filing: 1986-03-27
•
Granted: 1987-12-29
•
Expires: 2006-03-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel synthetic atrial peptides are provided with enhanced natriuretic properties by substituting one or two arginine residues for the N-terminal ser-ser in atriopeptins I, II and III and their physiologically acceptable salts, esters and amides.

Inventors

  • 👤 Foe S. Tjoeng
  • 👤 Kam F. Fok
  • 👤 Steven P. Adams

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 17:27
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/575; C07K14/58; C07K14/582; A; A61; A61P; A61P7/00; A61P7/10; C07K14/60; A61K; A61K38/00

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 40 words
A synthetic peptide having potent natriuretic activity comprising the following amino acid sequence: R.sub.1 -cys-phe-gly-gly-arg-X-asp-arg-ile-gly-ala-gln-ser-gly-leu-gly-cys-asn-R.sub.2 wherein R 1 =arg, arg-arg, leu-arg-arg, ser-leu-arg-arg, D-arg, D-arg-D-arg, R 2 =ser-phe, ser-phe-arg, ser-phe-arg-tyr, X=met, ile, or the physiologically acceptable salts, esters or amides thereof.
Claim 2
Dependent Claim 40 words
A synthetic peptide having potent natriuretic activity comprising the following amino acid sequence: R.sub.1 -cys-phe-gly-gly-arg-X-asp-arg-ile-gly-ala-gln-ser-gly-leu-gly-cys-asn-R.sub.2 wherein R 1 =arg, arg-arg, leu-arg-arg, ser-leu-arg-arg, D-arg, D-arg-D-arg, R 2 =ser-phe, ser-phe-arg, ser-phe-arg-tyr, X=met, ile, or the physiologically acceptable salts, esters or amides thereof.
Claim 3
Dependent Claim 18 words
A peptide of claim 1 in the oxidized form having a disulfide bond between the two cysteine residues.
Claim 4
Dependent Claim 17 words
A peptide of claim 1 in which the amide is a mono- or di-lower alkyl substituted amide.
Claim 5
Dependent Claim 10 words
A peptide of claim 1 in which X is ile.
Claim 6
Dependent Claim 10 words
A peptide of claim 2 in which X is ile.
Claim 7
Dependent Claim 11 words
A peptide of claim 5 in which R 2 is ser-phe-arg-tyr.
Claim 8
Dependent Claim 15 words
A peptide of claim 5 in which R 2 is ser-phe-arg in the amide form.
Claim 9
Dependent Claim 11 words
A peptide of claim 3 in which the amide is ethylamide.
Claim 10
Dependent Claim 11 words
A peptide of claim 7 in which the amide is ethylamide.
Claim 11
Dependent Claim 11 words
A peptide of claim 1 in which R 1 is arg.
Claim 12
Dependent Claim 11 words
A peptide of claim 1 in which R 1 is arg-arg.
Claim 13
Dependent Claim 11 words
A peptide of claim 2 in which R 1 is arg.
Claim 14
Dependent Claim 11 words
A peptide of claim 2 in which R 1 is arg-arg.
Claim 15
Dependent Claim 15 words
A peptide of claim 11 in which R 2 is ser-phe-arg in the amide form.
Claim 16
Dependent Claim 11 words
A peptide of claim 14 in which the amide is ethylamide.
Claim 17
Dependent Claim 33 words
A method for producing natriuresis, diuresis, vasodilation or change in renal blood flow in a mammal comprising administering to said mammal a therapeutically effective amount of a peptide as defined in claim 1.

References Cited (Backward Citations)

US4496544A Cited
US4508712A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-12-28 1991-06-29 1991-12-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-12-28 1995-06-29 1995-12-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-12-28 1999-06-29 1999-12-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag